Anatumomab mafenatox - CAS:1370261-50-9

您当前的位置：

Anatumomab mafenatox

目录号 : KM36816 CAS No. : 1370261-50-9

Data Sheet 产品使用指南

Anatumomab mafenatox (ABR-214936) 是一种 73 KDa 识别肿瘤相关抗原 5T4 的重组蛋白，5T4 则在恶性肿瘤中广泛表达。Anatumomab mafenatox 介于 SEA 的修饰形式和小鼠 Fab 之间。据报道，Anatumomab mafenatox 的主要副作用包括发烧、低血压、疼痛、恶心和嗜睡。5T4

规格	价格	是否有货	数量
1mg	询价	In-stock
5mg	询价	In-stock

加入购物车大包装询价

Other Forms of Rapamycin:

Cergutuzumab In-stock
Crefmirlimab In-stock
Zanolimumab In-stock
CNTO-860 In-stock
Prezalumab In-stock

KKL Med 的所有产品和服务仅用于科学研究，不能被用于人体，兽医，我们也不向个人提供产品和服务。

生物活性	Anatumomab mafenatox (ABR-214936) is a 73 KDa recombinant protein to recognize the tumor-associated antigen 5T4, which is widely expressing in malignancy. Anatumomab mafenatox is between a modified form of SEA and a murine Fab. The main side effects of Anatumomab mafenatox are reported to include fever, low blood pressure, pain, nausea and drowsiness.
CAS号	1370261-50-9
储存方式	Store at -20˚C